AQP4 and myeloid sarcoma: A recent study has accordingly shown a significantly lower PBVC/y in NMOSD-AQP4 patients compared to MS patients [24], thus suggesting, together with our findings, that brain atrophy might be related to neuropathological mechanisms that are exclusive to MS.